Global Implantable Drug Delivery Devices 麻豆原创 Research Report 2025

Publication ID:

PB504255299

Publication Date:

April 16, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Implantable Drug Delivery Devices was valued at US$ 518 million in the year 2024 and is projected to reach a revised size of US$ 735 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Implantable drug delivery devices are an alternative system that can achieve effective delivery with lower drug concentrations, and as a result, minimise side-effects whilst increasing patient compliance.
BD, B.Braun, AngioDynamics, Smiths Medical and Teleflex, etc. are the leading products in the international market, accounting for 85.5% of the global market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Implantable Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Drug Delivery Devices.
The Implantable Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Implantable Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Implantable Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BD
B.Braun
AngioDynamics
Smiths Medical
Teleflex
Cook Medical
Fresenius
Vygon
PFM Medical
Districlass
Linhwa
Segment by Type
Titanium Drug Delivery System
Plastic Drug Delivery System
Segment by Application
Intravenous Chemotherapy
Nutrition Support Therapy
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Implantable Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Implantable Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Implantable Drug Delivery Devices 麻豆原创 Overview
1.1 Product Definition
1.2 Implantable Drug Delivery Devices by Type
1.2.1 Global Implantable Drug Delivery Devices 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Titanium Drug Delivery System
1.2.3 Plastic Drug Delivery System
1.3 Implantable Drug Delivery Devices by Application
1.3.1 Global Implantable Drug Delivery Devices 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Intravenous Chemotherapy
1.3.3 Nutrition Support Therapy
1.4 Global Implantable Drug Delivery Devices 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Implantable Drug Delivery Devices Revenue 2020-2031
1.4.2 Global Implantable Drug Delivery Devices Sales 2020-2031
1.4.3 Global Implantable Drug Delivery Devices 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Implantable Drug Delivery Devices 麻豆原创 Competition by Manufacturers
2.1 Global Implantable Drug Delivery Devices Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Implantable Drug Delivery Devices Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Implantable Drug Delivery Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Implantable Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Implantable Drug Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Implantable Drug Delivery Devices, Product Type & Application
2.7 Global Key Manufacturers of Implantable Drug Delivery Devices, Date of Enter into This Industry
2.8 Global Implantable Drug Delivery Devices 麻豆原创 Competitive Situation and Trends
2.8.1 Global Implantable Drug Delivery Devices 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Implantable Drug Delivery Devices Players 麻豆原创 Share by Revenue
2.8.3 Global Implantable Drug Delivery Devices 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Implantable Drug Delivery Devices 麻豆原创 Scenario by Region
3.1 Global Implantable Drug Delivery Devices 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Implantable Drug Delivery Devices Sales by Region: 2020-2031
3.2.1 Global Implantable Drug Delivery Devices Sales by Region: 2020-2025
3.2.2 Global Implantable Drug Delivery Devices Sales by Region: 2026-2031
3.3 Global Implantable Drug Delivery Devices Revenue by Region: 2020-2031
3.3.1 Global Implantable Drug Delivery Devices Revenue by Region: 2020-2025
3.3.2 Global Implantable Drug Delivery Devices Revenue by Region: 2026-2031
3.4 North America Implantable Drug Delivery Devices 麻豆原创 Facts & Figures by Country
3.4.1 North America Implantable Drug Delivery Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Implantable Drug Delivery Devices Sales by Country (2020-2031)
3.4.3 North America Implantable Drug Delivery Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Implantable Drug Delivery Devices 麻豆原创 Facts & Figures by Country
3.5.1 Europe Implantable Drug Delivery Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Implantable Drug Delivery Devices Sales by Country (2020-2031)
3.5.3 Europe Implantable Drug Delivery Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Implantable Drug Delivery Devices 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Implantable Drug Delivery Devices 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Implantable Drug Delivery Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Implantable Drug Delivery Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Implantable Drug Delivery Devices 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Implantable Drug Delivery Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Implantable Drug Delivery Devices Sales by Country (2020-2031)
3.7.3 Latin America Implantable Drug Delivery Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Implantable Drug Delivery Devices 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Implantable Drug Delivery Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Implantable Drug Delivery Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Implantable Drug Delivery Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Implantable Drug Delivery Devices Sales by Type (2020-2031)
4.1.1 Global Implantable Drug Delivery Devices Sales by Type (2020-2025)
4.1.2 Global Implantable Drug Delivery Devices Sales by Type (2026-2031)
4.1.3 Global Implantable Drug Delivery Devices Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Implantable Drug Delivery Devices Revenue by Type (2020-2031)
4.2.1 Global Implantable Drug Delivery Devices Revenue by Type (2020-2025)
4.2.2 Global Implantable Drug Delivery Devices Revenue by Type (2026-2031)
4.2.3 Global Implantable Drug Delivery Devices Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Implantable Drug Delivery Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Implantable Drug Delivery Devices Sales by Application (2020-2031)
5.1.1 Global Implantable Drug Delivery Devices Sales by Application (2020-2025)
5.1.2 Global Implantable Drug Delivery Devices Sales by Application (2026-2031)
5.1.3 Global Implantable Drug Delivery Devices Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Implantable Drug Delivery Devices Revenue by Application (2020-2031)
5.2.1 Global Implantable Drug Delivery Devices Revenue by Application (2020-2025)
5.2.2 Global Implantable Drug Delivery Devices Revenue by Application (2026-2031)
5.2.3 Global Implantable Drug Delivery Devices Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Implantable Drug Delivery Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD Implantable Drug Delivery Devices Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 B.Braun
6.2.1 B.Braun Company Information
6.2.2 B.Braun Description and Business Overview
6.2.3 B.Braun Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 B.Braun Implantable Drug Delivery Devices Product Portfolio
6.2.5 B.Braun Recent Developments/Updates
6.3 AngioDynamics
6.3.1 AngioDynamics Company Information
6.3.2 AngioDynamics Description and Business Overview
6.3.3 AngioDynamics Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AngioDynamics Implantable Drug Delivery Devices Product Portfolio
6.3.5 AngioDynamics Recent Developments/Updates
6.4 Smiths Medical
6.4.1 Smiths Medical Company Information
6.4.2 Smiths Medical Description and Business Overview
6.4.3 Smiths Medical Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Smiths Medical Implantable Drug Delivery Devices Product Portfolio
6.4.5 Smiths Medical Recent Developments/Updates
6.5 Teleflex
6.5.1 Teleflex Company Information
6.5.2 Teleflex Description and Business Overview
6.5.3 Teleflex Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teleflex Implantable Drug Delivery Devices Product Portfolio
6.5.5 Teleflex Recent Developments/Updates
6.6 Cook Medical
6.6.1 Cook Medical Company Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cook Medical Implantable Drug Delivery Devices Product Portfolio
6.6.5 Cook Medical Recent Developments/Updates
6.7 Fresenius
6.7.1 Fresenius Company Information
6.7.2 Fresenius Description and Business Overview
6.7.3 Fresenius Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fresenius Implantable Drug Delivery Devices Product Portfolio
6.7.5 Fresenius Recent Developments/Updates
6.8 Vygon
6.8.1 Vygon Company Information
6.8.2 Vygon Description and Business Overview
6.8.3 Vygon Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vygon Implantable Drug Delivery Devices Product Portfolio
6.8.5 Vygon Recent Developments/Updates
6.9 PFM Medical
6.9.1 PFM Medical Company Information
6.9.2 PFM Medical Description and Business Overview
6.9.3 PFM Medical Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 PFM Medical Implantable Drug Delivery Devices Product Portfolio
6.9.5 PFM Medical Recent Developments/Updates
6.10 Districlass
6.10.1 Districlass Company Information
6.10.2 Districlass Description and Business Overview
6.10.3 Districlass Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Districlass Implantable Drug Delivery Devices Product Portfolio
6.10.5 Districlass Recent Developments/Updates
6.11 Linhwa
6.11.1 Linhwa Company Information
6.11.2 Linhwa Description and Business Overview
6.11.3 Linhwa Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Linhwa Implantable Drug Delivery Devices Product Portfolio
6.11.5 Linhwa Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Implantable Drug Delivery Devices Industry Chain Analysis
7.2 Implantable Drug Delivery Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Drug Delivery Devices Production Mode & Process Analysis
7.4 Implantable Drug Delivery Devices Sales and 麻豆原创ing
7.4.1 Implantable Drug Delivery Devices Sales Channels
7.4.2 Implantable Drug Delivery Devices Distributors
7.5 Implantable Drug Delivery Devices Customer Analysis
8 Implantable Drug Delivery Devices 麻豆原创 Dynamics
8.1 Implantable Drug Delivery Devices Industry Trends
8.2 Implantable Drug Delivery Devices 麻豆原创 Drivers
8.3 Implantable Drug Delivery Devices 麻豆原创 Challenges
8.4 Implantable Drug Delivery Devices 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

BD
B.Braun
AngioDynamics
Smiths Medical
Teleflex
Cook Medical
Fresenius
Vygon
PFM Medical
Districlass
Linhwa

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.